Roosevelt Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.42M | Sell |
40,423
-39
| -0.1% | -$5.6K | 0.39% | 54 |
|
|
2022
Q2 | $6.2M | Sell |
40,462
-3
| -0% | -$458 | 0.45% | 52 |
|
|
2022
Q1 | $6.56M | Sell |
40,465
-412
| -1% | -$59.8K | 0.39% | 52 |
|
|
2021
Q4 | $5.54M | Buy |
40,877
+4,977
| +14% | +$588K | 0.31% | 55 |
|
|
2021
Q3 | $3.87M | Hold |
35,900
| – | – | 0.24% | 61 |
|
|
2021
Q2 | $4.04M | Sell |
35,900
-1,540
| -4% | -$173K | 0.24% | 59 |
|
|
2021
Q1 | $4.05M | Buy |
37,440
+3,124
| +9% | +$334K | 0.27% | 59 |
|
|
2020
Q4 | $3.68M | Buy |
34,316
+36
| +0.1% | +$3.46K | 0.26% | 57 |
|
|
2020
Q3 | $3M | Buy |
34,280
+30,766
| +876% | +$2.9M | 0.24% | 61 |
|
|
2020
Q2 | $345K | Sell |
3,514
-718
| -17% | -$63.2K | 0.03% | 129 |
|
|
2020
Q1 | $322K | Buy |
4,232
+31
| +0.7% | +$2.64K | 0.04% | 112 |
|
|
2019
Q4 | $372K | Buy |
4,201
+110
| +3% | +$9.13K | 0.04% | 121 |
|
|
2019
Q3 | $310K | Buy |
4,091
+153
| +4% | +$10.5K | 0.04% | 125 |
|
|
2019
Q2 | $286K | Sell |
3,938
-465
| -11% | -$36.5K | 0.03% | 124 |
|
|
2019
Q1 | $355K | Sell |
4,403
-193
| -4% | -$15.8K | 0.04% | 118 |
|
|
2018
Q4 | $424K | Hold |
4,596
| – | – | 0.05% | 141 |
|
|
2018
Q3 | $435K | Sell |
4,596
-94
| -2% | -$8.91K | 0.04% | 118 |
|
|
2018
Q2 | $435K | Sell |
4,690
-35,290
| -88% | -$3.45M | 0.04% | 117 |
|
|
2018
Q1 | $3.78M | Sell |
39,980
-1,762
| -4% | -$194K | 0.36% | 71 |
|
|
2017
Q4 | $4.04M | Sell |
41,742
-66
| -0.2% | -$6.22K | 0.37% | 69 |
|
|
2017
Q3 | $3.71M | Buy |
41,808
+215
| +0.5% | +$16.4K | 0.34% | 80 |
|
|
2017
Q2 | $3.02M | Sell |
41,593
-381
| -0.9% | -$25.6K | 0.28% | 87 |
|
|
2017
Q1 | $2.73M | Buy |
41,974
+34,989
| +501% | +$2.2M | 0.25% | 96 |
|
|
2016
Q4 | $437K | Buy |
6,985
+1,040
| +17% | +$63.5K | 0.04% | 143 |
|
|
2016
Q3 | $375K | Buy |
5,945
+188
| +3% | +$12.2K | 0.03% | 144 |
|
|
2016
Q2 | $356K | Sell |
5,757
-186
| -3% | -$11.3K | 0.03% | 145 |
|
|
2016
Q1 | $339K | Sell |
5,943
-175
| -3% | -$9.75K | 0.03% | 143 |
|
|
2015
Q4 | $362K | Sell |
6,118
-532
| -8% | -$30.6K | 0.02% | 182 |
|
|
2015
Q3 | $362K | Buy |
6,650
+600
| +10% | +$39.1K | 0.02% | 188 |
|
|
2015
Q2 | $406K | Sell |
6,050
-310
| -5% | -$20.2K | 0.02% | 194 |
|
|
2015
Q1 | $372K | Sell |
6,360
-132
| -2% | -$7.97K | 0.02% | 193 |
|
|
2014
Q4 | $425K | Buy |
6,492
+1,092
| +20% | +$68.8K | 0.02% | 191 |
|
|
2014
Q3 | $312K | Sell |
5,400
-108
| -2% | -$6K | 0.02% | 205 |
|
|
2014
Q2 | $311K | Buy |
5,508
+308
| +6% | +$16.2K | 0.01% | 199 |
|
|
2014
Q1 | $267K | Sell |
5,200
-1
| -0% | -$51 | 0.01% | 202 |
|
|
2013
Q4 | $275K | Buy |
5,201
+1
| +0% | +$49 | 0.01% | 235 |
|
|
2013
Q3 | $232K | Sell |
5,200
-100
| -2% | -$4.43K | 0.01% | 248 |
|
|
2013
Q2 | $219K | Buy |
+5,300
| New | +$232K | 0.01% | 245 |
|
Other funds holding ABBV
Roosevelt Investment Group's ABBV Position: Q3 2022 in Review
Roosevelt Investment Group reduced its AbbVie (ABBV) stake by 0.1% in Q3 2022, selling an estimated $5.6K and leaving 40,423 shares worth $5.42M. The position accounts for 0.39% of the portfolio, ranked #54.
Roosevelt Investment Group first reported a position in ABBV in Q2 2013 and has held it in 38 quarters since. The position peaked at $6.56M in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Roosevelt Investment Group held 40,423 shares of AbbVie worth $5.42M as of Q3 2022.
- Roosevelt Investment Group sold 39 AbbVie shares in Q3 2022, an estimated $5.6K.
- AbbVie made up 0.39% of Roosevelt Investment Group's portfolio in Q3 2022, its #54 holding.
- Roosevelt Investment Group first reported a position in AbbVie in Q2 2013 and has held it in 38 quarters since.
- Roosevelt Investment Group's AbbVie position peaked at $6.56M in Q1 2022.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.